E2F2 represses cell cycle regulators to maintain quiescence

Cell Cycle

Volumn 7, Issue 24, 2008, Pages 3915-3927

  Infante, Arantza ^a   Laresgoiti, Usua ^a   Fernández Rueda, Jon ^a   Fullaondo, Asier ^a   Galán, Javier ^b   Díaz Uriarte, Ramón ^b   Malumbres, Marcos ^b   Field, Seth J ^c   Zubiaga, Ana M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; E2F; G1 S transition; Gene expression; Knockout mouse; Microarrays; T lymphocytes

Indexed keywords

TRANSCRIPTION FACTOR E2F2;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 58049194004     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.24.7379     Document Type: Article

References (55)

1. Bracken A, Ciro M, Cocito A, Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci 2004; 29:409-17.
2. Dimova DK, Dyson N. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005; 24:2810-26.
3. Trimarchi J, Lees J. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3:11-20.
4. Johnson D, Schwarz J, Cress W, Nevins J. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365:349-52.
5. 1 checkpoint. Mol Cell Biol 1996; 16:6917-25.
6. Müller H, Moroni M, Vigo E, Petersen B, Bartek J, Helin K. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol 1997;17:5508-20.
7. Verona R, Moberg K, Estes S, Starz M, Vernon J, Lees J. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 1997; 17:7268-82.
8. Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H, et al. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 2008;14:62-75.
9. Panagiotis Zalmas L, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS, et el. DNA-damage response control of E2F7 and E2F8. EMBO Rep 2008; 9:252-9.
10. Müller H, Bracken A, Vernell R, Moroni M, Christians F, Grassilli E, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev 2001; 15:267-85.
11. Young A, Nagarajan R, Longmore G. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway. Oncogene 2003; 22:7209-17.
12. Aslanian A, Iaquinta P, Verona R, Lees J. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 2004; 18:1413-22.
13. Wang D, Russell J, Johnson D. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol Cell Biol 2000; 20:3417-24.
14. Wells J, Boyd K, Fry C, Bartley S, Farnham P. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 2000; 20:5797-807.
15. DeGregori J, Johnson D. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr Mol Med 2006; 6:739-48.
16. 1 control. Mol Cell 2000; 6:729-35.
17. Scheijen B, Bronk M, van der Meer T, De Jong D, Bernards R. High incidence of thymic epithelial tumors in E2F2 transgenic mice. J Biol Chem 2004; 279:10476-83.
18. Murga M, Fernández-Capetillo O, Field S, Moreno B, Borlado L, Fujiwara Y, et al. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 2001; 15:959-70.
19. Zhu J, Field S, Gore L, Thompson M, Yang H, Fujiwara Y, et al. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol 2001; 21:8547-64.
20. Opavsky R, Tsai S, Guimond M, Arora A, Opavska J, Becknell B, et al. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci USA 2007; 104:15400-5.
21. Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, et al. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J Clin Invest 2004; 113:1398-407.
22. Dirlam A, Spike BT, Macleod KF. Deregulated E2F-2 underlies cell cycle and maturation defects in Retinoblastoma null erythroblasts. Mol Cell Biol 2007; 27:8713-28.
23. Persengiev SP, Li J, Poulin ML, Kilpatrick DL. E2F2 converts reversibly differentiated PC12 cells to an irreversible, neurotrophin-dependent state. Oncogene 2001; 20:5124-31.
24. Field S, Tsai F, Kuo F, Zubiaga AM, Kaelin WJ, Livingston D, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85:549-61.
25. Humbert P, Verona R, Trimarchi J, Rogers C, Dandapani S, Lees J. E2f3 is critical for normal cellular proliferation. Genes Dev 2000; 14:690-703.
26. 1 that controls entry into the cell cycle. Mol Cell Biol 2003; 23:2351-61.
27. Smyth G. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3.
28. Smyth G, Speed T. Normalization of cDNA microarray data. Methods 2003; 31:265-73.
29. Yang Y, Dudoit S, Luu P, Lin D, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30:15.
30. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003; 19:368-75.
31. Hosack D, Dennis GJ, Sherman B, Lane H, Lempicki R. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4:70.
32. Latres E, Malumbres M, Sotillo R, Martín J, Ortega S, Martín-Caballero J, et al. Limited overlapping roles of p15(INK4b) and p18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J 2000; 19:3496-506.
33. Cook J, Park C, Burke T, Leone G, DeGregori J, Engel A, et al. Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci USA 2002; 99:1347-52.
34. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young R, et al. E2F integrates cell cycle progression with DNA repair, replication and G(2)/M checkpoints. Genes Dev 2002; 16:245-56.
35. Weinmann A, Yan P, Oberley M, Huang T, Farnham P. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002; 16:235-44.
36. Wu L, Timmers C, Maiti B, Saavedra H, Sang L, Chong G, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001; 414:457-62.
37. 1/S progression and cellular transformation. J Biol Chem 2006; 281:36124-31.
38. Timmers C, Sharma N, Opavsky R, Maiti B, Wu L, Wu J, et al. E2f1, E2f2 and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol 2007; 27:65-78.
39. Blow JJ, Gillespie PJ. Replication licensing and cancer-a fatal entanglement? Nat Rev Cancer 2008; 8:799-806.
40. Almasan A, Yin Y, Kelly R, Lee E, Bradley A, Li W, et al. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995; 92:5436-40.
41. Dannenberg J, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000; 14:3051-64.
42. 1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol 1996; 16:2402-7.
43. Sage J, Mulligan G, Attardi L, Miller A, Chen S, Williams B, et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 2000; 14:3037-50.
44. Hurford RJ, Cobrinik D, Lee M, Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997; 11:1447-63.
45. Mulligan G, Wong J, Jacks T. p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol 1998; 18:206-20.
46. Lees J, Saito M, Vidal M, Valentine M, Look T, Harlow E, et al. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 1993; 13:7813-25.
47. Vairo G, Livingston DM, Ginsberg D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev 1995; 9:869-81.
48. Korenjak M, Taylor-Harding B, Binné U, Satterlee J, Stevaux O, Aasland R, et al. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 2004; 119:181-93.
49. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson S, Velmurugan S, et al. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 2007; 26:539-51.
50. Osterloh L, von Eyss B, Schmit F, Rein L, Hübner D, Samans B, et al. The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis. EMBO J 2007; 26:144-57.
51. García I, Murga M, Vicario A, Field S, Zubiaga AM. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ 2000; 11:91-8.
52. Palmero I, Murga M, Zubiaga AM, Serrano M. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2. Oncogene 2002; 21:2939-47.
53. Méndez J, Stillman B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol 2000; 20:8602-12.
54. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72:9873-80.
55. Kong L, Chang J, Bild A, Nevins J. Compensation and specificity of function within the E2F family. Oncogene 2007; 26:321-7.